|
WampocapDrug - Wampocap The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Niacin
Strength -
500MG
Applicant -
MEDPOINTE PHARM HLC
New Drug Application (NDA) Number -
011073
Product Number -
003
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Medpointe Pharmaceuticals Medpointe Healthcare Inc
Wampocap
Neomycin Sulfate-triamcinolone Acetonide Eq 3.5mg Base/gm;0.1% Ointment; Topical
Neomycin Sulfate-triamcinolone Acetonide Eq 3.5mg Base/gm;0.1% Ointment; Topical Nevanac 0.1% Suspension/drops; Ophthalmic Natrecor 1.5mg/vial For Solution; Intravenous Netromycin Eq 100mg Base/ml Injectable; Injection Netromycin Eq 10mg Base/ml Injectable; Injection Netromycin Eq 25mg Base/ml Injectable; Injection Viramune 50mg/5ml Suspension; Oral Viramune 200mg Tablet; Oral Wampocap 500mg Capsule; Oral NewDrugInformation |